Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1

Status

Terminated 3Withdrawn 1

Sponsor Class

OTHER 68INDUSTRY 13NIH 4OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Prostatic Neoplasms 1Leukoplakia, Oral 1Gallbladder Neoplasms 1Bile Duct Neoplasms 1

Interventions

Cyclophosphamide 385Specimen Handling 370Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Interventional × Photochemotherapy × Clear all
NCT00571558 2014-10-09

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Terminated
15 enrolled
Head & Neck

Leukoplakia, Oral

NCT00253617 2013-04-04

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 3 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

NCT00005808 2013-02-07

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

National Cancer Institute (NCI)

Phase 1 Terminated
54 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00005067 2013-01-16

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
24 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡